1. Home
  2. JRSH vs BTAI Comparison

JRSH vs BTAI Comparison

Compare JRSH & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$3.20

Market Cap

39.1M

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JRSH
BTAI
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
35.6M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
JRSH
BTAI
Price
$3.20
$1.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.00
$26.67
AVG Volume (30 Days)
70.3K
285.4K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
6.27%
N/A
EPS Growth
56.25
N/A
EPS
0.15
N/A
Revenue
$145,812,006.00
N/A
Revenue This Year
$11.64
N/A
Revenue Next Year
$10.06
$261.81
P/E Ratio
$21.33
N/A
Revenue Growth
24.43
N/A
52 Week Low
$2.81
$1.17
52 Week High
$3.70
$8.08

Technical Indicators

Market Signals
Indicator
JRSH
BTAI
Relative Strength Index (RSI) 48.32 50.49
Support Level $3.03 $1.50
Resistance Level $3.52 $1.72
Average True Range (ATR) 0.10 0.10
MACD -0.02 0.01
Stochastic Oscillator 18.77 50.94

Price Performance

Historical Comparison
JRSH
BTAI

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: